Posted 7th January 2019 by Jane Williams
It was a pleasure to welcome key opinion leaders to a discussion on accelerating the impact of AI through 100% digitization of the pathology workflow. Chaired by Peter Hamilton, Head of Research at Philips Digital & Computational Pathology, barriers to adoption, what drives the need and how do we reap the benefits were all on the agenda.
If you weren’t able to make the panel discussion, this six-part blog series will uncover what was discussed. Alternatively, you can watch the recording here.
Posted 5th December 2018 by Jane Williams
2018 will be remembered as a decisive year for immuno-oncology. In particular, Nobel Prize winners James Allison of MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo of Kyoto University in Japan lifted the field of immunotherapy to international recognition for those outside the scientific and medical communities. For the patient, these new alternatives to standard oncology therapies offer new hope for life-extending treatments using immunotherapy.
Posted 26th November 2018 by Jane Williams
The promise of an effective set of tools based on deep learning or other machine learning algorithms is the current buzz of the digital pathology markets. While the evolving tools, models and techniques are producing strongly positive results, there are still many factors which impact the utility and portability of models and tools being created across real-world data sets.
Posted 21st November 2018 by Jane Williams
Digital pathology is based on creating a digital replica of the glass slide, called whole slide image (WSI). This image is then viewed in a computer screen, which eliminates the need for using a microscope. Can you imagine working in a glassless environment, with better ergonomics and being able to immediately find the slide you need?
Posted 5th November 2018 by Jane Williams
The histological assessment of human tissue has emerged as a key challenge for the detection and treatment of cancer. Many tissue sections have to be processed in order to find those that contain cancer, which can be a timely and costly process. Similarly, procedures such as immunohistochemical scoring can be problematic for cases such as ER, PR, and HER2.
Posted 10th September 2018 by Jane Williams
At the recent Digital Pathology and AI Congress, Rebecca Calder and Daniel Stevens presented their research in the poster entitled: Preliminary Studies in the Use of the Foldscope Paper Microscope for Diagnostic Analysis of Crystals in Urine: Issues in the Analysis of Liquid Samples and Potential Applications in Low Budget/Low Tech Regions of the World. You can view the poster here.
Dr. Zev Leifer, who oversaw the project, describes the rationale.
Posted 31st August 2018 by Jane Williams
“There’s nothing wrong with the microscope.”
“Our Information Systems won’t integrate with other technology.”
“Change is hard.”
These are a couple of the concerns pathologists have about digital pathology. But as they learn more, pathologists are finding that their apprehension about going digital is holding them back from reaping significant benefits. They are also discovering that old methods can’t compete against today’s digital solutions.
Posted 15th August 2018 by Jane Williams
At the Digital Pathology and AI Conference in New York City, it was interesting to consider the different beliefs represented about Artificial Intelligence.